-
1
-
-
25444500137
-
Treatment of cognitive dysfunction in schizophrenia
-
Peuskens J, Demily C, Thibaut F. Treatment of cognitive dysfunction in schizophrenia. Clin Ther 2005;27 (Suppl A):S25-S37.
-
(2005)
Clin Ther
, vol.27
, Issue.SUPPL. A
-
-
Peuskens, J.1
Demily, C.2
Thibaut, F.3
-
2
-
-
7544244277
-
Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS
-
Green, MF, Kerns, SR, Heaton, RK. Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophr Res 2004;72:45-51.
-
(2004)
Schizophr Res
, vol.72
, pp. 45-51
-
-
Green, M.F.1
Kerns, S.R.2
Heaton, R.K.3
-
3
-
-
4344567028
-
Cognitive functioning, symptoms, and work in supported employment: A review and heuristic model
-
McGurk SR, Mueser KT. Cognitive functioning, symptoms, and work in supported employment: A review and heuristic model. Schizophr Res 2004;70:147-173.
-
(2004)
Schizophr Res
, vol.70
, pp. 147-173
-
-
McGurk, S.R.1
Mueser, K.T.2
-
4
-
-
33748792553
-
Schizophrenia patients with cognitive deficits: Factors associated with costs
-
Patel A, Everitt B, Knapp M, Reeder C, Grant D, Ecker C, Wykes T. Schizophrenia patients with cognitive deficits: Factors associated with costs. Schizophr Bull 2006;32:776-785.
-
(2006)
Schizophr Bull
, vol.32
, pp. 776-785
-
-
Patel, A.1
Everitt, B.2
Knapp, M.3
Reeder, C.4
Grant, D.5
Ecker, C.6
Wykes, T.7
-
5
-
-
0037237511
-
Insight: Its relationship with cognitive function, brain volume and symptoms in schizophrenia
-
Rossell SL, Coakes J, Shapleske J, Woodruff PW, David AS. Insight: Its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med 2003;33:111-119.
-
(2003)
Psychol Med
, vol.33
, pp. 111-119
-
-
Rossell, S.L.1
Coakes, J.2
Shapleske, J.3
Woodruff, P.W.4
David, A.S.5
-
6
-
-
0034864426
-
Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: A discriminant function analysis
-
Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, Tobin A, O'Callaghan E. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: A discriminant function analysis. Eur Psychiatry 2001:16:293-298.
-
(2001)
Eur Psychiatry
, vol.16
, pp. 293-298
-
-
Donohoe, G.1
Owens, N.2
O'Donnell, C.3
Burke, T.4
Moore, L.5
Tobin, A.6
O'Callaghan, E.7
-
7
-
-
33746039741
-
Baseline neurocognitive deficits in the CATIE schizophrenia trial
-
Keefe RSE, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller del D, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 2006;31:2033-2046.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 2033-2046
-
-
Keefe, R.S.E.1
Bilder, R.M.2
Harvey, P.D.3
Davis, S.M.4
Palmer, B.W.5
Gold, J.M.6
Meltzer, H.Y.7
Green, M.F.8
Miller del, D.9
Canive, J.M.10
Adler, L.W.11
Manschreck, T.C.12
Swartz, M.13
Rosenheck, R.14
Perkins, D.O.15
Walker, T.M.16
Stroup, T.S.17
McEvoy, J.P.18
Lieberman, J.A.19
-
8
-
-
0037449586
-
What are the right targets for psychopharmacology?
-
Hyman SE, Fenton WS. What are the right targets for psychopharmacology? Science 2003;299:350-351
-
(2003)
Science
, vol.299
, pp. 350-351
-
-
Hyman, S.E.1
Fenton, W.S.2
-
9
-
-
2342475885
-
A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: Opening a closed book
-
Mishara, AL, Goldberg, TE. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: Opening a closed book. Biol Psychiatry 2004;55:1013-1022.
-
(2004)
Biol Psychiatry
, vol.55
, pp. 1013-1022
-
-
Mishara, A.L.1
Goldberg, T.E.2
-
10
-
-
0037097412
-
Another view of therapy for cognition in schizophrenia
-
Carpenter WT, Gold JM. Another view of therapy for cognition in schizophrenia. Biol Psychiatry 2002;51: 969-971.
-
(2002)
Biol Psychiatry
, vol.51
, pp. 969-971
-
-
Carpenter, W.T.1
Gold, J.M.2
-
11
-
-
0025222024
-
The effect of neuroleptics on cognitive and psychomotor function
-
King DJ. The effect of neuroleptics on cognitive and psychomotor function. Br J Psychiatry 1990; 157:799-811.
-
(1990)
Br J Psychiatry
, vol.157
, pp. 799-811
-
-
King, D.J.1
-
12
-
-
30944460855
-
HGDH Research Group. Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis
-
Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Rock SL, Woolson S, Tohen M, Tollefson GD, Sanger TM, Lieberman JA; HGDH Research Group. Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biol Psychiatry 2006:59:97-105.
-
(2006)
Biol Psychiatry
, vol.59
, pp. 97-105
-
-
Keefe, R.S.1
Seidman, L.J.2
Christensen, B.K.3
Hamer, R.M.4
Sharma, T.5
Sitskoorn, M.M.6
Rock, S.L.7
Woolson, S.8
Tohen, M.9
Tollefson, G.D.10
Sanger, T.M.11
Lieberman, J.A.12
-
13
-
-
0033021909
-
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis
-
Keefe RS, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis. Schizophr Bull 1999;25:201-222.
-
(1999)
Schizophr Bull
, vol.25
, pp. 201-222
-
-
Keefe, R.S.1
Silva, S.G.2
Perkins, D.O.3
Lieberman, J.A.4
-
14
-
-
0035140610
-
Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
-
Harvey PD, Keefe RS. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 2001; 158: 176-184.
-
(2001)
Am J Psychiatry
, vol.158
, pp. 176-184
-
-
Harvey, P.D.1
Keefe, R.S.2
-
15
-
-
21244448316
-
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
-
Woodward ND, Purdon SE, Meltzer HY, Zald DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacology 2005; 8:1-16.
-
(2005)
Int J Neuropsychopharmacology
, vol.8
, pp. 1-16
-
-
Woodward, N.D.1
Purdon, S.E.2
Meltzer, H.Y.3
Zald, D.H.4
-
16
-
-
0032977410
-
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
-
Meltzer HY, McGurk SR. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 1999:25:233-255.
-
(1999)
Schizophr Bull
, vol.25
, pp. 233-255
-
-
Meltzer, H.Y.1
McGurk, S.R.2
-
17
-
-
33745791791
-
Treatment of cognitive deficits in schizophrenia
-
Bowie CR, Harvey PD. Treatment of cognitive deficits in schizophrenia. Curr Opin Investig Drugs 2006;7: 608-613.
-
(2006)
Curr Opin Investig Drugs
, vol.7
, pp. 608-613
-
-
Bowie, C.R.1
Harvey, P.D.2
-
18
-
-
34547218379
-
Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison
-
Keefe RSE, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison. Am J Psychiatry 2007a;164: 1061-1071.
-
(2007)
Am J Psychiatry
, vol.164
, pp. 1061-1071
-
-
Keefe, R.S.E.1
Sweeney, J.A.2
Gu, H.3
Hamer, R.M.4
Perkins, D.O.5
McEvoy, J.P.6
Lieberman, J.A.7
-
19
-
-
33748786261
-
Measuring changes in functional status among patients with schizophrenia: The link with cognitive impairment
-
Matza LS, Buchanan R, Purdon S, Brewster-Jordan J, Zhao Y, Revicki DA. Measuring changes in functional status among patients with schizophrenia: The link with cognitive impairment. Schizophr Bull 2006;32: 666-678.
-
(2006)
Schizophr Bull
, vol.32
, pp. 666-678
-
-
Matza, L.S.1
Buchanan, R.2
Purdon, S.3
Brewster-Jordan, J.4
Zhao, Y.5
Revicki, D.A.6
-
20
-
-
33845912693
-
Is the superior efficacy of new generation antipsychotics an artifact of LOCF?
-
Leucht S, Engel RR, Baum J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF? Schizophr Bull 2007;33:183-191.
-
(2007)
Schizophr Bull
, vol.33
, pp. 183-191
-
-
Leucht, S.1
Engel, R.R.2
Baum, J.3
Davis, J.M.4
-
21
-
-
34247643916
-
CATIE Investigators and the Neurocognitive Working Group. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
-
Keefe RSE, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA; CATIE Investigators and the Neurocognitive Working Group. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch Gen Psychiatry 2007b;64:633-647.
-
(2007)
Arch Gen Psychiatry
, vol.64
, pp. 633-647
-
-
Keefe, R.S.E.1
Bilder, R.M.2
Davis, S.M.3
Harvey, P.D.4
Palmer, B.W.5
Gold, J.M.6
Meltzer, H.Y.7
Green, M.F.8
Capuano, G.9
Stroup, T.S.10
McEvoy, J.P.11
Swartz, M.S.12
Rosenheck, R.A.13
Perkins, D.O.14
Davis, C.E.15
Hsiao, J.K.16
Lieberman, J.A.17
-
22
-
-
0038148696
-
Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale
-
Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale. Schizophr Bull 2003;29:45-55.
-
(2003)
Schizophr Bull
, vol.29
, pp. 45-55
-
-
Keefe, R.S.1
Mohs, R.C.2
Bilder, R.M.3
Harvey, P.D.4
Green, M.F.5
Meltzer, H.Y.6
Gold, J.M.7
Sano, M.8
-
23
-
-
20844439028
-
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia
-
Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 2005;31:5-19.
-
(2005)
Schizophr Bull
, vol.31
, pp. 5-19
-
-
Buchanan, R.W.1
Davis, M.2
Goff, D.3
Green, M.F.4
Keefe, R.S.5
Leon, A.C.6
Nuechterlein, K.H.7
Laughren, T.8
Levin, R.9
Stover, E.10
Fenton, W.11
Marder, S.R.12
-
24
-
-
33645230162
-
Negative symptoms and cognitive deficits: What is the nature of their relationship?
-
Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: What is the nature of their relationship? Schizophr Bull 2006;32:250-258.
-
(2006)
Schizophr Bull
, vol.32
, pp. 250-258
-
-
Harvey, P.D.1
Koren, D.2
Reichenberg, A.3
Bowie, C.R.4
-
25
-
-
4444220908
-
-
Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR. Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria for our use. Biol Psychiatry 2004;56:301-307.
-
(2004)
Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria for our use. Biol Psychiatry
, vol.56
, pp. 301-307
-
-
Green, M.F.1
Nuechterlein, K.H.2
Gold, J.M.3
Barch, D.M.4
Cohen, J.5
Essock, S.6
Fenton, W.S.7
Frese, F.8
Goldberg, T.E.9
Heaton, R.K.10
Keefe, R.S.11
Kern, R.S.12
Kraemer, H.13
Stover, E.14
Weinberger, D.R.15
Zalcman, S.16
Marder, S.R.17
-
26
-
-
7544234237
-
Identification of separable cognitive factors in schizophrenia
-
Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004;72: 29-39.
-
(2004)
Schizophr Res
, vol.72
, pp. 29-39
-
-
Nuechterlein, K.H.1
Barch, D.M.2
Gold, J.M.3
Goldberg, T.E.4
Green, M.F.5
Heaton, R.K.6
-
27
-
-
0032697378
-
-
Hobart MP, Goldberg R, Bartko JJ, Gold JM. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: Convergent/discriminant validity and diagnostic group comparisons. Am J Psychiatry 1999;156:1951-1957.
-
Hobart MP, Goldberg R, Bartko JJ, Gold JM. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: Convergent/discriminant validity and diagnostic group comparisons. Am J Psychiatry 1999;156:1951-1957.
-
-
-
-
28
-
-
49949090992
-
-
Guidelines for computer based tests and interpretations. American Psychological Association, 1987.
-
Guidelines for computer based tests and interpretations. American Psychological Association, 1987.
-
-
-
-
29
-
-
0031903740
-
Neurocognitive deficits in schizophrenia: A quantitative review of the evidence
-
Heinrichs RW, Zakzanis KK. Neurocognitive deficits in schizophrenia: A quantitative review of the evidence. Neuropsychology 1998;12:426-445.
-
(1998)
Neuropsychology
, vol.12
, pp. 426-445
-
-
Heinrichs, R.W.1
Zakzanis, K.K.2
-
30
-
-
0034740718
-
Schizophrenia - progressive and massive decline in response readiness by episodes
-
Levander S, Jensen J, Grawe R, Tuninger E. Schizophrenia - progressive and massive decline in response readiness by episodes. Acta Psychiatr Scand 2001;408: 65-74.
-
(2001)
Acta Psychiatr Scand
, vol.408
, pp. 65-74
-
-
Levander, S.1
Jensen, J.2
Grawe, R.3
Tuninger, E.4
-
31
-
-
0141669337
-
Premorbid IQ and schizophrenia: Increasing cognitive reduction by episodes
-
Eberhard J, Riley F, Levander S. Premorbid IQ and schizophrenia: Increasing cognitive reduction by episodes. Eur Arch Psychiatry Clin Neurosci 2003;253:84-88.
-
(2003)
Eur Arch Psychiatry Clin Neurosci
, vol.253
, pp. 84-88
-
-
Eberhard, J.1
Riley, F.2
Levander, S.3
-
32
-
-
0034740721
-
Neuropsychological impairments in patients with schizophrenia: Stability and prediction of outcome
-
Grawe RW, Levander S. Neuropsychological impairments in patients with schizophrenia: Stability and prediction of outcome. Acta Psychiatr Scand 2001;408:60-64.
-
(2001)
Acta Psychiatr Scand
, vol.408
, pp. 60-64
-
-
Grawe, R.W.1
Levander, S.2
-
33
-
-
0034740719
-
Neuropsychological impairment in patients treated with depot neuroleptics: A longitudinal study
-
Tuninger E, Levander S. Neuropsychological impairment in patients treated with depot neuroleptics: a longitudinal study. Acta Psychiatr Scand 2001;408 (Suppl.):75-80.
-
(2001)
Acta Psychiatr Scand
, vol.408
, Issue.SUPPL.
, pp. 75-80
-
-
Tuninger, E.1
Levander, S.2
-
34
-
-
33747354009
-
Standardization and cross-validation study of cogtest an automated neurocognitive battery for use in clinical trials of schizophrenia
-
Barua P, Bilder R, Small A, Sharma T. Standardization and cross-validation study of cogtest an automated neurocognitive battery for use in clinical trials of schizophrenia. Schizophr Bull 2005;31:318.
-
(2005)
Schizophr Bull
, vol.31
, pp. 318
-
-
Barua, P.1
Bilder, R.2
Small, A.3
Sharma, T.4
-
35
-
-
0033960819
-
Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: A trial of risperidone versus haloperidol
-
Liu SK, Chen WJ, Chang CJ, Lin HN. Effects of atypical neuroleptics on sustained attention deficits in schizophrenia: A trial of risperidone versus haloperidol. Neuropsychopharmacology 2000;22:311-319
-
(2000)
Neuropsychopharmacology
, vol.22
, pp. 311-319
-
-
Liu, S.K.1
Chen, W.J.2
Chang, C.J.3
Lin, H.N.4
-
36
-
-
0036268547
-
Deficits in sustained attention in schizophrenia and affective disorders: Stable versus state-dependent markers
-
Liu SK, Chiu CH, Chang CJ, Hwang TJ, Hwu HG, Chen, WJ. Deficits in sustained attention in schizophrenia and affective disorders: Stable versus state-dependent markers. Am J Psychiatry 2002; 159:975-982.
-
(2002)
Am J Psychiatry
, vol.159
, pp. 975-982
-
-
Liu, S.K.1
Chiu, C.H.2
Chang, C.J.3
Hwang, T.J.4
Hwu, H.G.5
Chen, W.J.6
-
37
-
-
32844471494
-
Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: A randomized, double-blind comparison of olanzapine vs. clozapine
-
Bender S, Dittmann-Balcar A, Schall U, Wolstein J, Klimke A, Riedel M, Vorbach EU, Kühn KU, Lambert M, Dittmann RW, Naber D. Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: A randomized, double-blind comparison of olanzapine vs. clozapine. Int J Neuropsychopharmacol 2006;9:135-145.
-
(2006)
Int J Neuropsychopharmacol
, vol.9
, pp. 135-145
-
-
Bender, S.1
Dittmann-Balcar, A.2
Schall, U.3
Wolstein, J.4
Klimke, A.5
Riedel, M.6
Vorbach, E.U.7
Kühn, K.U.8
Lambert, M.9
Dittmann, R.W.10
Naber, D.11
-
38
-
-
0032570747
-
Cognitive processing efficiency in schizophrenia: Generalized versus domain specific deficits
-
Schatz J. Cognitive processing efficiency in schizophrenia: Generalized versus domain specific deficits. Schizophr Res 1998;30:41-49.
-
(1998)
Schizophr Res
, vol.30
, pp. 41-49
-
-
Schatz, J.1
-
39
-
-
0034670524
-
A new look at reaction time in schizophrenia
-
Gale HJ, Holzman PS. A new look at reaction time in schizophrenia. Schizophr Res 2000:46:149-165.
-
(2000)
Schizophr Res
, vol.46
, pp. 149-165
-
-
Gale, H.J.1
Holzman, P.S.2
-
40
-
-
0034670502
-
Reaction time, symptom profiles and course of illness in schizophrenia
-
Ngan ET, Liddle PR Reaction time, symptom profiles and course of illness in schizophrenia. Schizophr Res 2000;46:195-201.
-
(2000)
Schizophr Res
, vol.46
, pp. 195-201
-
-
Ngan, E.T.1
Liddle, P.R.2
-
41
-
-
32044468522
-
The detection of neurocognitive decline in schizophrenia using the Mindstreams Computerized Cognitive Test Battery
-
Ritsner MS, Blumenkrantz H, Dubinsky T, Dwolatzky T. The detection of neurocognitive decline in schizophrenia using the Mindstreams Computerized Cognitive Test Battery. Schizophr Res 2006;82:39-49.
-
(2006)
Schizophr Res
, vol.82
, pp. 39-49
-
-
Ritsner, M.S.1
Blumenkrantz, H.2
Dubinsky, T.3
Dwolatzky, T.4
-
42
-
-
33847065797
-
Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB
-
Levaux MN, Potvin S, Sepehry AA, Sablier J, Mendrek A, Stip E. Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB. Eur Psychiatry 2007;22:104-115.
-
(2007)
Eur Psychiatry
, vol.22
, pp. 104-115
-
-
Levaux, M.N.1
Potvin, S.2
Sepehry, A.A.3
Sablier, J.4
Mendrek, A.5
Stip, E.6
-
43
-
-
0034773263
-
Computerized neurocognitive scanning. II. The profile of schizophrenia
-
Gur RC, Ragland JD, Moberg PJ, Bilker WB, Kohler C, Siegel SJ, Gur RE. Computerized neurocognitive scanning. II. The profile of schizophrenia. Neuropsychopharmacology 2001 ;25:777-788.
-
(2001)
Neuropsychopharmacology
, vol.25
, pp. 777-788
-
-
Gur, R.C.1
Ragland, J.D.2
Moberg, P.J.3
Bilker, W.B.4
Kohler, C.5
Siegel, S.J.6
Gur, R.E.7
-
44
-
-
0036877453
-
Paper-based versus computer-based assessment: Key factors associated with the test mode effect
-
Clariana RB, Wallace PE. Paper-based versus computer-based assessment: Key factors associated with the test mode effect. Br J Educ Technol 2002;33:593-602.
-
(2002)
Br J Educ Technol
, vol.33
, pp. 593-602
-
-
Clariana, R.B.1
Wallace, P.E.2
|